Photo of Biplab Lenin

Biplab Lenin

Partner in the Pharmaceutical, Healthcare & Life Sciences Practice at the Delhi NCR office of Cyril Amarchand Mangaldas. Biplab is an alumnus of IIT Kharagpur Law School. He is also an Industrial Biotech Engineer and a registered patent agent. Biplab specializes in regulatory, transactions, advisory and disputes pertaining to drugs, medical devices, healthcare, food, biotechnology, intellectual property matters including patents, plant variety and biodiversity. He can be reached at biplab.lenin@cyrilshroff.com

Beyond the Advisory - The Legal Framework Governing GLP-1 Drug Advertising

Summary: This article examines the reach of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, through the lens of key judicial pronouncements – from the Supreme Court’s ruling in Hamdard Dawakhana upholding the constitutionality of advertising restrictions to the Bombay High Court’s broad reading of Section 4 as a catch-all prohibition against misleading drug advertisements and the Supreme Court’s recent observations in the Patanjali matter. These rulings map the boundaries of what constitutes a prohibited advertisement and identify the penal consequences under the Drugs and Cosmetics Act, 1940 Act and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, for non-compliance with the Advisory.

Continue Reading Beyond the Advisory – The Legal Framework Governing GLP-1 Drug Advertising (Part 2)
From Awareness to Advertising: Re-examining the GLP-1 drug boundaries (Part 1)

Summary: Part 1 of this Article examines the CDSCO’s March 2026 Advisory directed at manufacturers, importers and marketing authorisation holders of GLP-1 receptor agonists, reinforcing that regulatory scrutiny of prescription-only medicine promotion will focus on substance over form. It prohibits all advertising — whether direct, surrogate, or influencer-led — that create brand recall among public.

Continue Reading From Awareness to Advertising: Re-examining the GLP-1 drug boundaries (Part 1)

Summary:India’s sexual wellness industry operates under a regulatory paradox wherein products are permitted to be legally sold, but advertising is restricted. This situation arises due to outdated obscenity laws, inconsistent enforcement, restrictive platform policies, and the lack of a dedicated regulatory framework, despite judicial progress and confirmation that such products are not classified as medical devices.

Continue Reading India’s sexual wellness industry caught between prohibition, perception and profit
Claims, Compliance and Credibility: Changing Face of Food Regulation in India

Summary: India’s food regulations have evolved from focusing mainly on hygiene to closely monitoring advertising and health claims. In recent years, enforcement has shifted toward demanding stronger scientific evidence and India‑specific validation to back up product claims. While this may slow down approvals, it rewards businesses that invest in credible research, giving them a competitive edge over those relying only on marketing.

Continue Reading Claims, Compliance and Credibility: Changing Face of Food Regulation in India
The Cosmos of Cosmeceuticals in India

Summary: Cosmeceuticals are topical products with biologically active ingredients that blur the line between cosmetics and pharmaceuticals. Such products have gained significant market traction in India, yet occupy a regulatory grey zone with no independent legal status under the Drugs and Cosmetics Act, 1940. This ambiguity forces businesses to strategically navigate compliance by carefully crafting product claims to remain within the “cosmetic” category while avoiding the stricter regulatory requirements applicable to “drugs” or “medical devices”.

Continue Reading The Cosmos of Cosmeceuticals in India
Medical Device As Software: Has CDSCO Guidance Changed The Rules?

Summary: The CDSCO’s Draft Guidance on Medical Device Software only clarifies how the existing Medical Devices Rules apply to software across its lifecycle, but does not create any new regulatory requirements. Its significance lies in signalling a more structured, risk-based and lifecycle-oriented approach to regulating software-driven healthcare products in India.

Continue Reading Medical Device As Software: Has CDSCO Guidance Changed The Rules?
Curbing Hospital and Surgeon Promotions in India: Regulation of Live Surgery Broadcasts

Summary: The NMC has issued new guidelines restricting live surgery broadcasts to curb patient exploitation, ensure ethical safeguards, and prevent commercial misuse. The framework shifts focus towards pre-recorded simulations and controlled teaching environments to balance education with patient rights.

Continue Reading Curbing Hospital and Surgeon Promotions in India: Regulation of Live Surgery Broadcasts

In Part 1 of the blog post series, we explored the complex and multi-layered regulatory framework governing alcohol advertising and packaging in India. We discussed how both central and state laws — shaped by constitutional mandates, statutory provisions, and evolving self-regulatory guidelines — intersect to create a challenging compliance landscape. As we highlighted, the rise of surrogate advertising and the tightening grip of regulators have significantly reshaped industry practices. In this second part, we turn our focus to the fast-evolving regulatory environment specific to digital media, packaging and labelling norms, and the divergent approaches adopted by Indian states. As online platforms become increasingly central to brand communication and consumer engagement, and as product labelling becomes a site of regulatory scrutiny, it is essential to unpack the distinct legal developments shaping the alcohol industry’s future in India.

Continue Reading Pouring Over the Law: Navigating Alcohol Advertising & Packaging Regulations in India – Part 2
Pouring Over the Law: Navigating Alcohol Advertising & Packaging Regulations in India – Part 1

CAM Comment: Part 1 of this blog post series aims to shed light on the multi-layered regulatory framework surrounding the advertisement and promotion of alcoholic beverages in India.

Introduction

India presents a uniquely complex regulatory environment for the alcoholic beverages industry. Unlike many sectors governed primarily by central legislation, alcohol falls under the purview of states, creating a fragmented landscape of laws governing production, sale, advertising, and consumption. This complexity stems from the Indian Constitution, which places production,  possession, transport, purchase and sale of intoxicating liquors on the State List, granting states legislative power. This contrasts with the Directive Principle in Article 47, which encourages states to prohibit intoxicating drinks, highlighting an intrinsic conflict between public health objectives and the significant state revenue generated from alcohol excise duties.

Continue Reading Pouring Over the Law: Navigating Alcohol Advertising & Packaging Regulations in India – Part 1